Serious complications of bacteremia caused by viridans streptococci in neutropenic patients with cancer

Clinical Infectious Diseases

Volumn 31, Issue 5, 2000, Pages 1126-1130

  Marron, Anna ^a   Carratalà, Jordi ^a   Gonzaález Barca, Eva ^a   Fernández Sevilla, Alberto ^a   Alcaide, Fernando ^a   Gudiol, Francesc ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTAZIDIME; CYCLOPHOSPHAMIDE; ERYTHROMYCIN; IMIPENEM; PENICILLIN DERIVATIVE; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ALLOGENIC BONE MARROW TRANSPLANTATION; ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MEGADOSE; DRUG SENSITIVITY; FEMALE; HUMAN; MALE; MORTALITY; MUCOSA INFLAMMATION; NEUTROPENIA; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; SEPTIC SHOCK; STREPTOCOCCUS MITIS;

ADOLESCENT; ADULT; AGED; BACTEREMIA; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; NEOPLASMS; NEUTROPENIA; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS;

EID: 0034458539     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/317460     Document Type: Article

References (35)

1. Bacteremia due to viridans streptococcus in neutropenic patients with cancer: Clinical spectrum and risk factors
2. Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer
3. Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer
4. Prospective study of 288 episodes of bacteremia in neutropenic cancer patients in a single institution
5. Bacteremia due to viridans streptococci in neutropenic patients: A review
6. Streptococcal bacteremia in adult patients with leukemia undergoing aggressive chemotherapy. A review of 55 cases
7. The clinical spectrum of infections with viridans streptococci in bone marrow transplant patients
8. Streptococcus mitis sepsis in bone marrow transplant patients receiving oral antimicrobial prophylaxis
9. Septicemia and shock syndrome due to viridans streptococci: A case-control study of predisposing factors
10. Viridans streptococcal shock in bone marrow transplantation patients
11. Levels of cytokines and cytokine inhibitors in the neutropenic patient with α-hemolytic streptococcus shock syndrome
12. Bacteremia due to viridans streptococci that are highly resistant to penicillin: Increase among neutropenic patients with cancer
13. Emergence of high rates of antimicrobial resistance among viridans streptococci in the United States
14. Antimicrobial susceptibility of viridans group streptococci in Taiwan with an emphasis on the high rates of resistance to penicillin and macrolides in Streptococcus oralis
15. Life-threatening infections due to penicillin-resistant viridans streptococci
16. Molecular relationships and antimicrobial susceptibilities of viridans group streptococci isolated from blood of neutropenic cancer patients
17. In vitro activities of fluoroquinolones against antibiotic-resistant blood culture isolates of viridans group streptococci from across Canada
18. Streptococcus
19. Nomenclature for aerobic and facultative bacteria
20. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: Approved standard
21. Performance standards for antimicrobial susceptibility testing
22. Streptococcus viridans bacteremia following autologous peripheral blood stem cell transplantation
23. Streptococcal septicaemia following autologous bone marrow transplantation in children treated with high-dose chemotherapy
24. Viridans streptococcal bacteremia and viridans streptococcal shock syndrome in neutropenic patients: Comparison between children and adults receiving chemotherapy or undergoing bone marrow transplantation
25. Cytosine arabinoside as a major risk factor for Streptococcus viridans septicemia following bone marrow transplantation: A 5-year prospective study
26. Viridans streptococcal shock syndrome during bone marrow transplantation
27. Viridans streptococcal bacteremia in patients with neutropenia
28. In vitro activities of 22 β-lactam antibiotics against penicillin-resistant and penicillin-susceptible viridans group streptococci isolated from blood
29. Outcomes of bacteremia in patients with cancer and neutropenia: Observations from two decades of epidemiological and clinical trials
30. Prophylaxis with fluoroquinolones for bacterial infections in neutropenic patients: A meta-analysis
31. New uses for new and old quinolones and the challenge of resistance
32. Reduction of fever, streptococcal bacteremia in granulocytopenic patients with cancer. A trial of oral penicillin or placebo combined with pefloxacin
33. A randomized trial of roxithromycin in patients with acute leukemia and bone marrow transplant recipients receiving fluoroquinolone prophylaxis
34. In vitro activities of eight macrolide antibiotics and RP-59500 (quinupristin-dalfopristin) against viridans group streptococci isolated from blood of neutropenic cancer patients
35. Prophylaxis and treatment of chemo- and radiotherapy-induced oral mucositis: Are there new strategies?